Administration of Simvastatin has been demonstrated to effectively modulate the expression of PI3K-AKT-eNOS in endothelial cells, reducing the incidence of CVS following brain hemorrhage (Sugawara et al., 2008). Here, AKT1 is linked to intracranial hemorrhage.